Benjamin Mirman1, Ian Ikeda1, Zhiqi Zhang1, Yuhong Liu1, Lucy Yu1, Afshin Ehsan1, Jun Feng1, Frank Sellke2. 1. Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI. 2. Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI. Electronic address: fsellke@lifespan.org.
Abstract
BACKGROUND: Neuropeptide Y acts directly on the vasculature as a cotransmitter with norepinephrine for an augmented contraction. Little, however, is known about the effects of neuropeptide Y on the microvasculature of human skeletal muscle. Neuropeptide Y signaling has not been studied in the setting of cardiac surgery and cardiopulmonary bypass. We investigated the role of neuropeptide Y signaling on vasomotor tone in the microvessels of human skeletal muscle, as well as the effect of cardiopulmonary bypass on neuropeptide Y-induced responsiveness. METHODS: Specimens taken from intercostal muscles were collected from patients, pre- and post-cardiopulmonary bypass, undergoing coronary artery bypass grafting or cardiac valve surgery (n = 8/group). Microvessels (157 ± 47 microns) were isolated in vitro in a no-flow state. Arterial microvascular responses to a neuropeptide Y agonist, a Y1 receptor antagonist, phenylephrine, and the coadministration of neuropeptide Y and phenylephrine were examined. The abundance and localization of the Y1 receptor were measured using Western blot and immunofluorescence, respectively. RESULTS: Arterial microvessels showed responsiveness to the neuropeptide Y agonist (10-9 to 4 × 10-7 mol/L) both before and after cardiopulmonary bypass, reaching a 12.5% vasoconstriction from the baseline luminal diameter. With administration of the Y1 receptor antagonist after neuropeptide Y, the contractile response was eliminated (n = 3/group, P = .04). No difference in vasoconstriction was observed between pre- and post-cardiopulmonary bypass groups (P = .73). The coadministration of neuropeptide Y and phenylephrine (10-9 to 10-4 mol/L) elicited no difference in vasoconstriction (n = 7/group, P = .06 both pre- and post-cardiopulmonary bypass) when compared with phenylephrine alone (10-9 to 10-4 mol/L). No change in the protein expression or localization of the Y1 receptor was detected by Western blotting (n = 6/group, P = .44) or immunofluorescence (n = 6/group, P = .13). CONCLUSION: Neuropeptide Y induced vasoconstriction, suggesting that neuropeptide Y may play an important role in the regulation of the peripheral microvasculature. There was no change in microvascular responsiveness to neuropeptide Y after cardiopulmonary bypass nor were there any synergistic effects of neuropeptide Y on phenylephrine-induced vasoconstriction in the skeletal muscle microvasculature.
BACKGROUND:Neuropeptide Y acts directly on the vasculature as a cotransmitter with norepinephrine for an augmented contraction. Little, however, is known about the effects of neuropeptide Y on the microvasculature of human skeletal muscle. Neuropeptide Y signaling has not been studied in the setting of cardiac surgery and cardiopulmonary bypass. We investigated the role of neuropeptide Y signaling on vasomotor tone in the microvessels of human skeletal muscle, as well as the effect of cardiopulmonary bypass on neuropeptide Y-induced responsiveness. METHODS: Specimens taken from intercostal muscles were collected from patients, pre- and post-cardiopulmonary bypass, undergoing coronary artery bypass grafting or cardiac valve surgery (n = 8/group). Microvessels (157 ± 47 microns) were isolated in vitro in a no-flow state. Arterial microvascular responses to a neuropeptide Y agonist, a Y1 receptor antagonist, phenylephrine, and the coadministration of neuropeptide Y and phenylephrine were examined. The abundance and localization of the Y1 receptor were measured using Western blot and immunofluorescence, respectively. RESULTS: Arterial microvessels showed responsiveness to the neuropeptide Y agonist (10-9 to 4 × 10-7 mol/L) both before and after cardiopulmonary bypass, reaching a 12.5% vasoconstriction from the baseline luminal diameter. With administration of the Y1 receptor antagonist after neuropeptide Y, the contractile response was eliminated (n = 3/group, P = .04). No difference in vasoconstriction was observed between pre- and post-cardiopulmonary bypass groups (P = .73). The coadministration of neuropeptide Y and phenylephrine (10-9 to 10-4 mol/L) elicited no difference in vasoconstriction (n = 7/group, P = .06 both pre- and post-cardiopulmonary bypass) when compared with phenylephrine alone (10-9 to 10-4 mol/L). No change in the protein expression or localization of the Y1 receptor was detected by Western blotting (n = 6/group, P = .44) or immunofluorescence (n = 6/group, P = .13). CONCLUSION:Neuropeptide Y induced vasoconstriction, suggesting that neuropeptide Y may play an important role in the regulation of the peripheral microvasculature. There was no change in microvascular responsiveness to neuropeptide Y after cardiopulmonary bypass nor were there any synergistic effects of neuropeptide Y on phenylephrine-induced vasoconstriction in the skeletal muscle microvasculature.
Authors: H Chen; C Fetscher; R F Schäfers; G Wambach; T Philipp; M C Michel Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1996-02 Impact factor: 3.000
Authors: Marc Ruel; Tanveer A Khan; Pierre Voisine; Cesario Bianchi; Frank W Sellke Journal: Eur J Cardiothorac Surg Date: 2004-11 Impact factor: 4.191
Authors: Jun Feng; Yuhong Liu; Louis M Chu; Richard T Clements; Kamal R Khabbaz; Michael P Robich; Cesario Bianchi; Frank W Sellke Journal: Ann Thorac Surg Date: 2011-09 Impact factor: 4.330
Authors: Michael P Robich; Robina Matyal; Louis M Chu; Jun Feng; Shu-Hua Xu; Roger J Laham; Philip E Hess; Cesario Bianchi; Frank W Sellke Journal: J Mol Cell Cardiol Date: 2010-09-06 Impact factor: 5.000
Authors: Olivia Ziegler; Kelsey Anderson; Yuhong Liu; Afshin Ehsan; James Fingleton; Neel Sodha; Jun Feng; Frank W Sellke Journal: Surgery Date: 2019-09-04 Impact factor: 3.982
Authors: Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Neel R Sodha; Robert M Osipov; Frank W Sellke Journal: Surgery Date: 2010-01-15 Impact factor: 3.982
Authors: Nicholas Sellke; Caroline Gordon; Isabella Lawandy; Anastassia Y Gorvitovskaia; Laura A Scrimgeour; James G Fingleton; Frank W Sellke; Jun Feng Journal: J Surg Res Date: 2018-05-22 Impact factor: 2.192
Authors: Cheryl M J Tan; Peregrine Green; Nidi Tapoulal; Adam J Lewandowski; Paul Leeson; Neil Herring Journal: Front Physiol Date: 2018-09-19 Impact factor: 4.566
Authors: Laura A Scrimgeour; Ian Ikeda; Nicholas C Sellke; Guangbin Shi; Jun Feng; Sevdenur Cizginer; Afshin Ehsan; Neel R Sodha; Frank W Sellke Journal: J Card Surg Date: 2021-10-28 Impact factor: 1.620